The Economic Times

Capacity scale-ups to drive Epigral's Rs 5,000 crore target by FY31: CMD Maulik Patel

Epigral is planning a target revenue of 5000 crore by 2030-31, aided by upcoming production scale-ups in CPVC Resin and Epichlorohyrdin (ECH). The company expects to reach Rs 2,900 crore in revenue this fiscal year following revenue of Rs 2,500-2,530 crore in 2026. Capacity expansions for CPVC Resin and ECH will commence soon, contributing partially this year and more significantly in the next fiscal year.